Prospective discovery of LasB inhibitors by integrating generative design, free energy ranking, and experimental validation
Identifying synthetically accessible, potent ligands from vast chemical space remains a major challenge in drug discovery, particularly because experimental synthesis and testing are costly and low throughput. Here, we present a fully open-source computational-experimental workflow that integrates fragment-based de novo molecular design with rigorous alchemical absolute binding free-energy…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.
